2-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Gastroenterology...
Clinical Nutrition
Browse
ALL OF MEDICINE
Gastroenterology & Hepatology
Biliary Tract
Clinical Nutrition
Colon & Rectum
Disorders of Neurogastroenterology & Motility
Endoscopy
Esophagus
Gastrointestinal Cancers
Gastrointestinal Infections
Inflammatory Bowel Disease
Liver Biology & Pathobiology
Liver Failure & Liver Disease
Pancreas
Small Intestine
Stomach & Duodenum
Related Sections
Diabetes & Obesity
Renal & Gastrointestinal Problems in Critical Care
selected for
My F1000 Medicine
Browse > Gastroenterology & Hepatology > Clinical Nutrition
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 3. Select Page:
1
2
3
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
New Finding
Controversial
Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury.
Marchbank T, K Limdi J, …, Elia G, J Playford R
Aliment Pharmacol Ther
2008 Jun 26 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Ingvar Bjarnason
Evaluated 30 Sep 2008
Recommended
F1000 Factor
3.0
Confirmation
Fructose intolerance in children presenting with abdominal pain.
Gomara RE, Halata MS, …, See MC, Medow MS
J Pediatr Gastroenterol Nutr
2008 Sep
47
(3):303-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Carlo Di Lorenzo
Evaluated 22 Sep 2008
Recommended
F1000 Factor
3.0
New Finding
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhea-predominant irritable bowel syndrome.
Zeng J, Li YQ, …, Yang J, Liu CH
Aliment Pharmacol Ther
2008 Jul 30 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Anton Emmanuel
Evaluated 16 Sep 2008
Recommended
F1000 Factor
3.0
New Finding
Tolerance to extensively heated milk in children with cow's milk allergy.
Nowak-Wegrzyn A, Bloom KA, …, Wanich N, Sampson HA
J Allergy Clin Immunol
2008 Aug
122
(2):342-7, 347.e1-2 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| James Gern
Evaluated 15 Sep 2008
Must Read
F1000 Factor
6.4
Changes
Clinical Practice
Confirmation
New Finding
Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.
Soylemez Wiener R, Wiener DC, Larson RJ
JAMA
2008 Aug 27
300
(8):933-44 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Bruce Bistrian / Ian Herrick
First evaluation 11 Sep 2008 | Latest evaluation 24 Nov 2008
Recommended
F1000 Factor
3.0
Hypothesis
Controversial
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
Dupuis L, Corcia P, …, Loeffler JP, Meininger V
Neurology
2008 Mar 25
70
(13):1004-9 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Paolo Vineis with Valentina Gallo
Evaluated 5 Sep 2008
Must Read
F1000 Factor
6.0
Hypothesis
Dietary flavonoids inhibit the anti-cancer effects of the proteasome inhibitor Bortezomib.
Liu FT, Agrawal SG, …, Newland AC, Jia L
Blood
2008 Jul 16 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Xavier Leleu with Laurent Pascal
Evaluated 29 Aug 2008
Recommended
F1000 Factor
3.0
Confirmation
Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.
Plank LD, Gane EJ, …, Donaghy AJ, McCall JL
Hepatology
2008 Aug
48
(2):557-66 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Michael Trauner with Gernot Zollner
Evaluated 21 Aug 2008
Recommended
F1000 Factor
3.2
Hypothesis
New Finding
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
Jatoi A, Dakhil SR, …, Novotny PJ, Loprinzi CL
Cancer
2007 Sep 15
110
(6):1396-403 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Victor Chang / Mellar Davis
First evaluation 18 Aug 2008 | Latest evaluation 9 Sep 2008
Recommended
F1000 Factor
3.0
Confirmation
Death after PEG: results of the National Confidential Enquiry into Patient Outcome and Death.
Johnston SD, Tham TC, Mason M
Gastrointest Endosc
2008 Aug
68
(2):223-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Nigel Beejay with Philip Woodland
Evaluated 15 Aug 2008
top of page
Page 1 of 3. Select Page:
1
2
3
>>
Display
10
/
20
/
50
papers per page
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info